术后早期皮质醇和促肾上腺皮质激素正常化值可预测库欣病术后未缓解
这项单中心回顾性病例对照研究纳入257例库欣病患者的291例次经蝶手术,计算术后即刻皮质醇或促肾上腺皮质激素减去术前促肾上腺皮质激素释放激素兴奋试验后水平的正常化早期术后值。结果显示,皮质醇和促肾上腺皮质激素的正常化早期术后值均可预测早期和中期未缓解。
要点
- 皮质醇正常化早期术后值预测早期未缓解的校正OR为1.1(95%CI 1.0, 1.1;P=0.016)。
- 促肾上腺皮质激素正常化早期术后值预测早期未缓解的校正OR为1.0(95%CI 1.0, 1.0;P=0.048)。
- 皮质醇正常化早期术后值预测中期未缓解的HR为1.1(95%CI 1.0, 1.1;P=0.023)。
核心结论
- 皮质醇和促肾上腺皮质激素的正常化早期术后值可预测库欣病经蝶手术后的未缓解。
研究设计与样本
- 回顾性病例对照研究,纳入2003年12月至2016年7月单中心收治的257例有生化证据的库欣病患者,共291例次连续经蝶手术。
- 早期缓解在术后10天评估,中期缓解在11个月评估。
主要发现
- 皮质醇正常化早期术后值预测早期未缓解的校正OR为1.1(95%CI 1.0, 1.1;P=0.016),AUROC为0.78(95%CI 0.61, 0.95)。
- 促肾上腺皮质激素正常化早期术后值预测早期未缓解的校正OR为1.0(95%CI 1.0, 1.0;P=0.048),AUROC为0.80(95%CI 0.61, 0.98)。
- 皮质醇正常化早期术后值预测中期未缓解的HR为1.1(95%CI 1.0, 1.1;P=0.023)。
- 促肾上腺皮质激素正常化早期术后值预测中期未缓解的HR为1.0(95%CI 1.0, 1.0;P=0.025)。
关键数值与推荐
- 正常化早期术后值定义为术后即刻皮质醇或促肾上腺皮质激素水平减去术前促肾上腺皮质激素释放激素兴奋试验后水平。
- 早期未缓解预测采用逻辑回归,中期缓解预测采用Cox回归,预测能力以受试者工作特征曲线下面积(AUROC)量化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Perioperative increases in adrenocorticotropic hormone (ACTH) and cortisol mimic results of corticotropin-releasing hormone (CRH) stimulation testing. This phenomenon may help identify patients with residual adenoma after transsphenoidal surgery (TSS) for Cushing disease (CD). OBJECTIVE: To predict nonremission after TSS for CD. DESIGN: Retrospective case-control study of patients treated at a single center from December 2003 until July 2016. Early and medium-term remission were assessed at 10 days and 11 months. PATIENTS AND SETTING: Two hundred and ninety-one consecutive TSS cases from 257 patients with biochemical evidence of CD seen at a clinical center. INTERVENTIONS: Normalized early postoperative values (NEPVs) for cortisol and ACTH were calculated as immediate postoperative cortisol or ACTH levels minus preoperative post-CRH-stimulation test levels. MAIN OUTCOME MEASURES: Prediction of early nonremission was evaluated using logistic regression. Prediction of medium-term remission was assessed using Cox regression. Predictive ability was quantified by area under the receiver operating characteristic curve (AUROC). RESULTS: NEPVs for cortisol and ACTH predicted early nonremission [adjusted odds ratio (OR): 1.1; 95% confidence interval (CI): 1.0, 1.1; P = 0.016 and adjusted OR: 1.0; 95% CI: 1.0, 1.0; P = 0.048, respectively]. AUROC for NEPV of cortisol was 0.78 (95% CI: 0.61, 0.95); for NEPV of ACTH, it was 0.80 (95% CI: 0.61, 0.98). NEPVs for cortisol and ACTH predicted medium-term nonremission [hazard ratio (HR): 1.1; 95% CI: 1.0, 1.1; P = 0.023 and HR: 1.0; 95% CI: 1.0, 1.0; P = 0.025, respectively]. CONCLUSIONS: NEPVs for cortisol and ACTH predicted nonremission after TSS for CD.
引用
- Asuzu D, Chatain GP, Hayes C, et al. Normalized Early Postoperative Cortisol and ACTH Values Predict Nonremission After Surgery for Cushing Disease. J Clin Endocrinol Metab. 2017. PMID: 28323961. doi:10.1210/jc.2016-3908
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。